Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia

Author： Balakrishnan Kumudha   Gandhi Varsha  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.4, 2012-04, pp. : 409-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Targeted Therapy for Protein and Lipid Kinases in Chronic Lymphocytic Leukemia

By  

Current Medicinal Chemistry, Vol. 19, Iss. 31, 2012-11 ,pp. : 5294-5318

Bentham Science Publishers

Access to resources Recommend Favorite

Novel and Emerging Drugs for Chronic Lymphocytic Leukemia

By  

Current Cancer Drug Targets, Vol. 12, Iss. 5, 2012-05 ,pp. : 471-483

Bentham Science Publishers

Access to resources Recommend Favorite

Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge

By  

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-09 ,pp. : 701-709

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions

By  

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-10 ,pp. : 710-720

Bentham Science Publishers

Access to resources Recommend Favorite

Pentostatin in chronic lymphocytic leukemia

By Sauter Craig   Lamanna Nicole   Weiss Mark A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1217-1222

Informa Healthcare

Access to resources Recommend Favorite